These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1202 related articles for article (PubMed ID: 15990814)

  • 1. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus.
    Larghi A; Lightdale CJ; Memeo L; Bhagat G; Okpara N; Rotterdam H
    Gastrointest Endosc; 2005 Jul; 62(1):16-23. PubMed ID: 15990814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer.
    Thota PN; Sada A; Sanaka MR; Jang S; Lopez R; Goldblum JR; Liu X; Dumot JA; Vargo J; Zuccarro G
    Surg Endosc; 2017 Mar; 31(3):1336-1341. PubMed ID: 27444824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of endoscopic ultrasound findings on clinical decision making in Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
    Bulsiewicz WJ; Dellon ES; Rogers AJ; Pasricha S; Madanick RD; Grimm IS; Shaheen NJ
    Dis Esophagus; 2014 Jul; 27(5):409-17. PubMed ID: 23016606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of conventional endosonography and endoscopic ultrasound-guided fine-needle aspiration in the assessment of patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma who have been referred for endoscopic ablation therapy.
    Shami VM; Villaverde A; Stearns L; Chi KD; Kinney TP; Rogers GB; Dye CE; Waxman I
    Endoscopy; 2006 Feb; 38(2):157-61. PubMed ID: 16479423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma.
    Scotiniotis IA; Kochman ML; Lewis JD; Furth EE; Rosato EF; Ginsberg GG
    Gastrointest Endosc; 2001 Dec; 54(6):689-96. PubMed ID: 11726843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of EUS in patients with suspected Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma: impact on endoscopic therapy.
    Bartel MJ; Wallace TM; Gomez-Esquivel RD; Raimondo M; Wolfsen HC; Woodward TA; Wallace MB
    Gastrointest Endosc; 2017 Aug; 86(2):292-298. PubMed ID: 27889544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EUS in the management of the patient with dysplasia in Barrett's esophagus.
    Savoy AD; Wallace MB
    J Clin Gastroenterol; 2005 Apr; 39(4):263-7. PubMed ID: 15758616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUS and EMR/ESD: is EUS in patients with Barrett's esophagus with high-grade dysplasia or intramucosal adenocarcinoma necessary prior to endoscopic mucosal resection?
    Waxman I
    Endoscopy; 2006 Jun; 38 Suppl 1():S2-4. PubMed ID: 16802213
    [No Abstract]   [Full Text] [Related]  

  • 11. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
    Lewis JT; Wang KK; Abraham SC
    Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem.
    Rusch VW; Levine DS; Haggitt R; Reid BJ
    Cancer; 1994 Aug; 74(4):1225-9. PubMed ID: 8055442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tumor characteristics and duplication of the muscularis mucosae on the endoscopic staging of superficial Barrett esophagus-related neoplasia.
    Mandal RV; Forcione DG; Brugge WR; Nishioka NS; Mino-Kenudson M; Lauwers GY
    Am J Surg Pathol; 2009 Apr; 33(4):620-5. PubMed ID: 19047893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.
    Reid BJ; Weinstein WM; Lewin KJ; Haggitt RC; VanDeventer G; DenBesten L; Rubin CE
    Gastroenterology; 1988 Jan; 94(1):81-90. PubMed ID: 3335302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
    Cameron AJ; Carpenter HA
    Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy.
    Mino-Kenudson M; Hull MJ; Brown I; Muzikansky A; Srivastava A; Glickman J; Park DY; Zuckerberg L; Misdraji J; Odze RD; Lauwers GY
    Gastrointest Endosc; 2007 Oct; 66(4):660-6; quiz 767, 769. PubMed ID: 17905005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus.
    Nijhawan PK; Wang KK
    Gastrointest Endosc; 2000 Sep; 52(3):328-32. PubMed ID: 10968845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.